Literature DB >> 16945740

Asymptomatic patients with diabetes mellitus should not be screened for coronary artery disease.

Raymond J Gibbons.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16945740     DOI： 10.1016/j.nuclcard.2006.06.130

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN： 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  5 in total

1.  Medscape's response to the Institute of Medicine Report: Crossing the quality chasm: a new health system for the 21st century.

Authors:  M Leavitt
Journal:  MedGenMed       Date:  2001-03-05

Review 2.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee.

Authors:  Thomas A Pearson; Steven N Blair; Stephen R Daniels; Robert H Eckel; Joan M Fair; Stephen P Fortmann; Barry A Franklin; Larry B Goldstein; Philip Greenland; Scott M Grundy; Yuling Hong; Nancy Houston Miller; Ronald M Lauer; Ira S Ockene; Ralph L Sacco; James F Sallis; Sidney C Smith; Neil J Stone; Kathryn A Taubert
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

3.  Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging.

Authors:  Navin Rajagopalan; Todd D Miller; David O Hodge; Robert L Frye; Raymond J Gibbons
Journal:  J Am Coll Cardiol       Date:  2005-01-04       Impact factor: 24.094

Review 4.  Optimal care of patients with type 2 diabetes mellitus and coronary artery disease.

Authors:  Robert L Frye
Journal:  Am J Med       Date:  2003-12-08       Impact factor: 4.965

5.  Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes.

Authors:  Todd D Miller; Navin Rajagopalan; David O Hodge; Robert L Frye; Raymond J Gibbons
Journal:  Am Heart J       Date:  2004-05       Impact factor: 4.749
  5 in total
  5 in total

Review 1.  Cardiac computed tomography and myocardial perfusion imaging for risk stratification in asymptomatic diabetic patients: a critical review.

Authors:  Ajay Yerramasu; Shreenidhi Venuraju Maggae; Avijit Lahiri; Dhakshinamurthy Vijay Anand
Journal:  J Nucl Cardiol       Date:  2007-12-26       Impact factor: 5.952

2.  Screening for asymptomatic coronary artery disease can reduce cardiovascular mortality and morbidity in type 2 diabetic patients.

Authors:  Carmine Gazzaruso; Adriana Coppola; Tiziana Montalcini; Cinzia Valenti; Gabriele Pelissero; Sebastiano Bruno Solerte; Fabrizio Salvucci; Pietro Gallotti; Arturo Pujia; Adriana Garzaniti; Andrea Giustina
Journal:  Intern Emerg Med       Date:  2011-02-05       Impact factor: 3.397

3.  Prevalence and predictors of an abnormal stress myocardial perfusion study in asymptomatic patients with type 2 diabetes mellitus.

Authors:  Arthur J H A Scholte; Joanne D Schuijf; Antje V Kharagjitsingh; Petra Dibbets-Schneider; Marcel P Stokkel; Ernst E van der Wall; Jeroen J Bax
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

4.  Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial.

Authors:  Lawrence H Young; Frans J Th Wackers; Deborah A Chyun; Janice A Davey; Eugene J Barrett; Raymond Taillefer; Gary V Heller; Ami E Iskandrian; Steven D Wittlin; Neil Filipchuk; Robert E Ratner; Silvio E Inzucchi
Journal:  JAMA       Date:  2009-04-15       Impact factor: 56.272

5.  Metabolic syndrome is not a predictor for cardiovascular events in Japanese patients with diabetes mellitus asymptomatic for coronary artery disease: a retrospective analysis of the J-ACCESS-2 study.

Authors:  Kenichi Nakajima; Yasuchika Takeishi; Shinro Matsuo; Yoshimitsu Yamasaki; Tsunehiko Nishimura
Journal:  J Nucl Cardiol       Date:  2012-11-30       Impact factor: 5.952
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.